Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. [electronic resource]
Producer: 20150105Description: 2930-6 p. digitalISSN:- 1528-0020
- Adult
- Aged
- Anemia, Hemolytic, Autoimmune -- drug therapy
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Autoantibodies -- immunology
- Erythropoietin -- therapeutic use
- Female
- Humans
- Immunoglobulins, Intravenous -- therapeutic use
- Immunologic Factors -- therapeutic use
- Immunosuppressive Agents -- therapeutic use
- Male
- Middle Aged
- Predictive Value of Tests
- Retrospective Studies
- Rituximab
- Severity of Illness Index
- Splenectomy
- Steroids -- therapeutic use
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.